Cefpodoxime Proxetil Dispersible Tablets
April 9, 2026CATROZYME
April 10, 2026Cefpodoxime Proxetil Dispersible Tablets
₹1,590.00
Yuvicef-100 is a broad-spectrum, third-generation cephalosporin antibiotic containing Cefpodoxime Proxetil as its active ingredient. It is available as dispersible tablets, making it easier to administer, especially for patients who have difficulty swallowing conventional tablets.
The dispersible formulation allows the tablet to be mixed with a small amount of water before oral intake, ensuring faster disintegration and convenient dosing.
Indications (Typical Uses)
Cefpodoxime Proxetil is commonly prescribed for the treatment of mild to moderate bacterial infections, including:
-
Acute otitis media
-
Pharyngitis and tonsillitis
-
Sinusitis
-
Community-acquired pneumonia
-
Skin and soft tissue infections
-
Urinary tract infections
Key Features
-
Broad-spectrum activity against Gram-positive and Gram-negative bacteria
-
Dispersible tablet for ease of administration
-
Suitable for pediatric and geriatric patients
-
Each pack contains 100 tablets (10 strips of 10 tablets each)
Dosage & Administration (General Guidance)
-
Disperse the tablet in a small amount of water (approx. 5–10 ml) and administer immediately.
-
Should preferably be taken with food to enhance absorption.
-
Dosage depends on infection type, severity, age, and renal function.
-
Always follow prescribing physician’s advice.
Storage Information
-
Store in a cool, dry place below 30°C.
-
Protect from moisture and light.
-
Keep out of reach of children.
Note
This is a prescription-only medicine. Do not use without medical consultation. Complete the full course of antibiotic as advised by the doctor to prevent antibiotic resistance.
Quick Product Details Table
| Parameter | Details |
|---|---|
| Product Name | Yuvicef-100 |
| Composition | Cefpodoxime Proxetil Dispersible Tablets |
| Pack Size | 10 x 10 Tablets |
| MRP | ₹1590 |
| Dosage Form | Dispersible Tablet |
Related products
-
UDIVIN-300
₹3,490.00




Reviews
There are no reviews yet.